Yoshiro Horai

2.2k total citations
89 papers, 1.0k citations indexed

About

Yoshiro Horai is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yoshiro Horai has authored 89 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Rheumatology, 21 papers in Pulmonary and Respiratory Medicine and 21 papers in Immunology. Recurrent topics in Yoshiro Horai's work include Systemic Lupus Erythematosus Research (25 papers), Vasculitis and related conditions (20 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Yoshiro Horai is often cited by papers focused on Systemic Lupus Erythematosus Research (25 papers), Vasculitis and related conditions (20 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Yoshiro Horai collaborates with scholars based in Japan, United States and Canada. Yoshiro Horai's co-authors include Atsushi Kawakami, Hideki Nakamura, Kunihiro Ichinose, Tomoki Origuchi, Mami Tamai, Shin‐ya Kawashiri, Toshimasa Shimizu, Naoki Iwamoto, Yoshikazu Nakashima and Tomohiro Koga and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Yoshiro Horai

85 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiro Horai Japan 18 476 326 273 189 154 89 1.0k
Toshimasa Shimizu Japan 17 390 0.8× 321 1.0× 229 0.8× 249 1.3× 149 1.0× 90 983
Toshiyuki Aramaki Japan 21 734 1.5× 329 1.0× 131 0.5× 158 0.8× 139 0.9× 76 1.2k
Joëlle Goetz France 17 357 0.8× 334 1.0× 313 1.1× 134 0.7× 151 1.0× 58 1.1k
Yasumori Izumi Japan 18 358 0.8× 424 1.3× 91 0.3× 333 1.8× 134 0.9× 88 1.1k
Adrianos Nezos Greece 22 425 0.9× 462 1.4× 576 2.1× 346 1.8× 281 1.8× 62 1.5k
Elisabeth Peen Norway 15 282 0.6× 202 0.6× 311 1.1× 82 0.4× 139 0.9× 26 823
Qingjun Wu China 19 507 1.1× 208 0.6× 90 0.3× 180 1.0× 232 1.5× 88 1.0k
Shoichi Fukui Japan 19 394 0.8× 557 1.7× 85 0.3× 386 2.0× 126 0.8× 86 1.3k
Christopher J. Lessard United States 19 476 1.0× 552 1.7× 630 2.3× 245 1.3× 206 1.3× 35 1.3k
Hsien‐Tzung Liao Taiwan 20 720 1.5× 417 1.3× 94 0.3× 263 1.4× 85 0.6× 80 1.1k

Countries citing papers authored by Yoshiro Horai

Since Specialization
Citations

This map shows the geographic impact of Yoshiro Horai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiro Horai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiro Horai more than expected).

Fields of papers citing papers by Yoshiro Horai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiro Horai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiro Horai. The network helps show where Yoshiro Horai may publish in the future.

Co-authorship network of co-authors of Yoshiro Horai

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiro Horai. A scholar is included among the top collaborators of Yoshiro Horai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiro Horai. Yoshiro Horai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Horai, Yoshiro, et al.. (2024). Effectiveness and Safety of Avacopan as a Combination Therapy with Glucocorticoids or Monotherapy in Patients with Microscopic Polyangiitis. Internal Medicine. 64(9). 1427–1433. 2 indexed citations
4.
Origuchi, Tomoki, Masataka Umeda, Tomohiro Koga, et al.. (2022). Comparison of complications during 1-year follow-up between remitting seronegative symmetrical synovitis with pitting edema syndrome and elderly-onset rheumatoid arthritis. Immunological Medicine. 45(3). 168–174. 3 indexed citations
5.
6.
Okamoto, Momoko, Mineaki Kitamura, Shuntaro Sato, et al.. (2020). Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis. Lara D. Veeken. 60(5). 2333–2341. 8 indexed citations
7.
Ichinose, Kunihiro, Kazuhiko Arima, Ayako Nishino, et al.. (2015). Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases. Clinical Immunology. 157(2). 114–120. 33 indexed citations
8.
Yoshimura, Shunsuke, Hideki Nakamura, Yoshiro Horai, et al.. (2015). Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients. Modern Rheumatology. 26(3). 384–390. 42 indexed citations
9.
Fukui, Shoichi, Naoki Iwamoto, Masataka Umeda, et al.. (2015). Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy. Medicine. 94(45). e1943–e1943. 6 indexed citations
10.
Nakashima, Yoshikazu, Hideki Nakamura, Yoshiro Horai, et al.. (2014). Comorbid case of IgG4-related disease and primary Sjögren's syndrome. Modern Rheumatology. 25(3). 462–467. 8 indexed citations
11.
Takagi, Yukinori, Misa Sumi, Hiroaki Nakamura, et al.. (2014). Ultrasonography as an additional item in the American College of Rheumatology classification of Sjogren's syndrome. Lara D. Veeken. 53(11). 1977–1983. 29 indexed citations
12.
Horai, Yoshiro, Tomohiro Koga, Akitomo Okada, et al.. (2013). Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases. Modern Rheumatology. 23(1). 190–194. 17 indexed citations
13.
Kawashiri, Shin‐ya, Takahisa Suzuki, Yoshikazu Nakashima, et al.. (2013). Confirmation of effectiveness of tocilizumab by ultrasonography and magnetic resonance imaging in biologic agent-naïve early-stage rheumatoid arthritis patients. Modern Rheumatology. 25(6). 948–953. 4 indexed citations
14.
Tamai, Mami, Kazuhiko Arima, Shin‐ya Kawashiri, et al.. (2013). Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach. Modern Rheumatology. 23(2). 254–259. 4 indexed citations
15.
Nakamura, Hideki, Yukitaka Ueki, Shigeki Saito, et al.. (2013). Development of Adult T-cell Leukemia in a Patient with Rheumatoid Arthritis Treated with Tocilizumab. Internal Medicine. 52(17). 1983–1986. 15 indexed citations
16.
Tamai, Mami, Kazuhiko Arima, Shin‐ya Kawashiri, et al.. (2012). Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach. Modern Rheumatology. 23(2). 254–259. 5 indexed citations
17.
Horai, Yoshiro, Tomohiro Koga, Akitomo Okada, et al.. (2012). Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases. Modern Rheumatology. 23(1). 190–194. 19 indexed citations
18.
Horai, Yoshiro, Remi Sumiyoshi, Yoshikazu Nakashima, et al.. (2012). Takayasu arteritis developing during treatment of ulcerative colitis with infliximab. Modern Rheumatology. 23(3). 572–576. 6 indexed citations
19.
Horai, Yoshiro, Tomoya Miyamura, Kazuaki Shimada, et al.. (2010). Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease. Journal of Clinical Pharmacy and Therapeutics. 37(1). 117–121. 20 indexed citations
20.
Miyamura, Tomoya, Koshiro Sonomoto, Masataka Nakamura, et al.. (2009). Discontinuation of etanercept in patients with rheumatoid arthritis who were in clinical remission. Clinical Rheumatology. 29(1). 87–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshimasa Shimizu Breakdown of academic impact, for papers by Toshiyuki Aramaki Breakdown of academic impact, for papers by Joëlle Goetz Breakdown of academic impact, for papers by Yasumori Izumi Breakdown of academic impact, for papers by Adrianos Nezos Breakdown of academic impact, for papers by Elisabeth Peen Breakdown of academic impact, for papers by Qingjun Wu Breakdown of academic impact, for papers by Shoichi Fukui Breakdown of academic impact, for papers by Christopher J. Lessard Breakdown of academic impact, for papers by Hsien‐Tzung Liao
Rankless by CCL
2026